Loss of heterozygosity of TRIM3 in malignant gliomas
<p>Abstract</p> <p>Background</p> <p>Malignant gliomas are frequent primary brain tumors associated with poor prognosis and very limited response to conventional chemo- and radio-therapies. Besides sharing common growth features with other types of solid tumors, gliomas...
Main Authors: | Dolder Béatrice, Taylor Elisabeth, Stiefel Urs, Boulay Jean-Louis, Merlo Adrian, Hirth Frank |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-02-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/71 |
Similar Items
-
Molecular biology techniques for loss of heterozygosity detection: the glioma example
by: Tiago D. P. Ramos, et al.
Published: (2015-06-01) -
A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
by: Lea Rod A, et al.
Published: (2010-05-01) -
Association of Loss of Heterozygosity and PTEN Gene Abnormalities with Paraclinical, Clinical Modalities and Survival Time of Glioma Patients in Malaysia
by: Jafri Malin Abdullah, et al.
Published: (2006-10-01) -
Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia
by: Abdullah, JM, et al. -
Association of loss of heterozygosity and PTEN gene abnormalities with paraclinical, clinical modalities and survival time of glioma patients in Malaysia
by: Abdullah, J.M, et al.
Published: (2006)